We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

TDUP:NASDAQThredUp Inc. Analysis

Data as of 2026-07-27 - not real-time

$6.01

Latest Price

8/10Risk

Risk Level: High

Executive Summary

ThredUp is trading just above a clear technical support level, while the short‑term moving average remains above the medium‑term average, suggesting modest upward bias but limited momentum. The MACD histogram is negative and the signal line is bearish, indicating recent price weakness, and volume has been trending lower, raising concerns about liquidity. Fundamentally, the company continues to generate revenue growth yet operates with negative operating and profit margins, and earnings per share remain in the red. Cash flow is positive but modest, and the balance sheet shows a debt‑to‑equity ratio that is relatively high for a consumer‑focused internet retailer. Valuation metrics are stretched, with a price‑to‑book multiple well above ten and a discounted cash‑flow estimate far below the current market price, implying the stock is priced for perfection. The beta is elevated, reflecting greater sensitivity to market swings, and 30‑day price volatility exceeds sixty percent, underscoring a high risk profile. The broader consumer cyclical and internet retail sector faces intense competition and shifting consumer preferences, adding sector‑specific headwinds. No dividend is paid, eliminating any income component for investors. Upcoming Q2 earnings release on August 5 could provide fresh insight, but the current data suggest limited upside potential. Overall, the combination of weak profitability, high valuation, and elevated market risk points to a cautious stance.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • price hovering just above technical support
  • bearish MACD and decreasing volume
  • negative earnings but positive cash flow

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • revenue growth offset by persistent margin erosion
  • valuation gap between market price and DCF fair value
  • high beta and volatility increasing exposure to market swings

Long Term

> 3 years
Cautious
Model confidence: 7/10

Key Factors

  • overvalued pricing relative to fundamentals
  • ongoing profitability challenges
  • elevated sector competition and high liquidity risk

Key Metrics & Analysis

Financial Health

Revenue Growth14.60%
Profit Margin-6.69%
P/E Ratio-100.2
ROE-37.19%
ROA-7.91%
Debt/Equity87.87
P/B Ratio13.1
Op. Cash Flow$9.7M
Free Cash Flow$8.1M

Technical Analysis

TrendNeutral
RSI46.6
Support$5.62
Resistance$7.17
MA 20$6.58
MA 50$5.58
MA 200$5.82
MACDBearish
VolumeDecreasing
Fear & Greed Index89.75

Valuation

Fair Value$1.44
Target Price$8.04
Upside/Downside33.78%
GradeOvervalued
TypeValue

Risk Assessment

Beta2.22
Volatility61.02%
Sector RiskHigh
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.